Literature DB >> 18691669

Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins.

Sebastien Farnaud1, Maryam Amini, Chiara Rapisarda, Richard Cammack, Tam Bui, Alex Drake, Robert W Evans, Yohan Suryo Rahmanto, Des R Richardson.   

Abstract

Melanotransferrin (MTf) is a member of the transferrin (Tf) family of iron (Fe)-binding proteins that was first identified as a cell-surface marker of melanoma. Although MTf has a high-affinity Fe-binding site that is practically identical to that of serum Tf, the protein does not play an essential role in Fe homeostasis and its precise molecular function remains unclear. A Zn(II)-binding motif, distinct from the Fe-binding site, has been proposed in human MTf based on computer modelling studies. However, little is known concerning the interaction of its proposed binding site(s) with metals and the consequences in terms of MTf conformation. For the first time, biochemical and spectroscopic techniques have been used in this study to characterise metal ion-binding to recombinant MTf. Initially, the binding of Fe to MTf was examined using 6M urea gel electrophoresis. Although four different iron-loaded forms were observed with serum Tf, only two forms were found with MTf, the apo-form and the N-monoferric holo-protein, suggesting a single high-affinity site. The presence of a single Fe(III)-binding site was also supported by EPR results which indicated that the Fe(III)-binding characteristics of MTf were unique, but somewhat comparable to the N-lobes of human serum Tf and chicken ovo-Tf. Circular dichroism (CD) analysis indicated that, as for Tf, no changes in secondary structure could be observed upon Fe(III)-binding. The ability of MTf to bind Zn(II) was also investigated using CD which demonstrated that the single high-affinity Fe-binding site was distinct from a potential Zn(II)-binding site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691669     DOI: 10.1016/j.biocel.2008.07.003

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

Review 1.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

2.  Exploring the Fe(III) binding sites of human serum transferrin with EPR at 275 GHz.

Authors:  Guinevere Mathies; Peter Gast; N Dennis Chasteen; Ashley N Luck; Anne B Mason; Edgar J J Groenen
Journal:  J Biol Inorg Chem       Date:  2014-12-24       Impact factor: 3.358

3.  Epithelial septate junction assembly relies on melanotransferrin iron binding and endocytosis in Drosophila.

Authors:  Katarína Tiklová; Kirsten-André Senti; Shenqiu Wang; Astrid Gräslund; Christos Samakovlis
Journal:  Nat Cell Biol       Date:  2010-10-10       Impact factor: 28.824

4.  An Endogenous Electron Spin Resonance (ESR) signal discriminates nevi from melanomas in human specimens: a step forward in its diagnostic application.

Authors:  Eleonora Cesareo; Liudmila Korkina; Gerardino D'Errico; Giuseppe Vitiello; Maria Simona Aguzzi; Francesca Passarelli; Jens Z Pedersen; Antonio Facchiano
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  EPR Study of Iron Ion Complexes in Human Blood.

Authors:  Ryszard Krzyminiewski; Zdzisław Kruczyński; Bernadeta Dobosz; Anna Zając; Andrzej Mackiewicz; Ewa Leporowska; Sandra Folwaczna
Journal:  Appl Magn Reson       Date:  2011-04-05       Impact factor: 0.831

6.  Complex of human Melanotransferrin and SC57.32 Fab fragment reveals novel interdomain arrangement with ferric N-lobe and open C-lobe.

Authors:  Kristyn Hayashi; Kenton L Longenecker; Yi-Liang Liu; Bryan Faust; Aditi Prashar; Johannes Hampl; Vincent Stoll; Sandro Vivona
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

7.  The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer.

Authors:  Yuanyuan Lei; Zhiliang Lu; Jianbing Huang; Ruochuan Zang; Yun Che; Shuangshuang Mao; Lingling Fang; Chengming Liu; Xinfeng Wang; Sufei Zheng; Nan Sun; Jie He
Journal:  Cell Death Dis       Date:  2020-10-30       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.